Punukollu Anuraag, Franklin Brodus A, Pineda Felipe Gutierrez, Kuhar Krish, Sayudo Iqbal F, Chen Hsien-Chung, Wouters Kim, Silva Anna Lydia Machado, Tripathi Manjul
Andhra Medical College, Visakhapatnam, India.
Global Health, Texas Children's Hospital, Houston, TX, USA.
Neurosurg Rev. 2024 Dec 30;48(1):13. doi: 10.1007/s10143-024-03156-8.
Rathke's cleft cysts (RCCs) are benign, cystic lesions that account for less than 5% of cases in the pediatric population. While asymptomatic RCCs often require only conservative management, symptomatic cases may necessitate surgical intervention. Advances in surgical techniques have improved the safety of these procedures. This comprehensive review and single-arm meta-analysis evaluates the outcomes of surgical management in pediatric patients. PubMed, Embase, and Web of Science were systematically searched for studies documenting RCC resection in pediatric patients (< 18 years). Outcomes of interest included symptomatic improvement (headache, visual impairment, endocrinopathy), postoperative complications, postoperative diabetes insipidus (DI), recurrence, and reoperation rate. Heterogeneity was assessed using I statistics, and a random-effects model was adopted. Twelve studies were included in the final analysis. The pooled proportion of headache improvement was 84% (95% CI: 73%-91%), with 65% of patients achieving complete resolution. Improvement of visual symptoms occurred in 87% of cases (95% CI: 63%-96%). The rate of improvement of endocrinopathy after surgery had an overall pooled rate of 48% (95% CI: 29%-69%). The rate of postoperative complications was 8% (95% CI: 4%-13%), and the incidence of new postoperative DI was 28% (95% CI: 18%-40%). The pooled incidence of cyst recurrence was 16% (95% CI: 11%-23%), while the incidence of reoperation was 14% (95% CI: 8%-24%).Surgery for RCC in pediatric patients offers high rates of symptomatic improvement for headaches and visual impairments, though improvement for endocrinopathy tends to be moderate. The procedure generally has a low risk of postoperative complications, but the incidence of new-onset DI is notable. While many patients experienced complete headache resolution, surgery should not be solely indicated for headache management. Surgical decisions must prioritize objective clinical factors, such as cyst characteristics, neurological impact, and endocrine dysfunction. Additionally, recurrence and reoperation rates are observed, highlighting the need for careful consideration of potential risks and individualized treatment planning. Future research should focus on refining surgical techniques and assessing long-term outcomes to optimize treatment strategies for pediatric RCC patients.
拉克氏裂囊肿(RCCs)是良性囊性病变,在儿科人群中占比不到5%。无症状的RCCs通常仅需保守治疗,而有症状的病例可能需要手术干预。手术技术的进步提高了这些手术的安全性。本综述和单臂荟萃分析评估了儿科患者手术治疗的结果。系统检索了PubMed、Embase和Web of Science数据库,以查找记录儿科患者(<18岁)RCC切除的研究。感兴趣的结果包括症状改善(头痛、视力障碍、内分泌病)、术后并发症、术后尿崩症(DI)、复发和再次手术率。使用I统计量评估异质性,并采用随机效应模型。最终分析纳入了12项研究。头痛改善的合并比例为84%(95%CI:73%-91%),65%的患者头痛完全缓解。87%的病例视力症状得到改善(95%CI:63%-96%)。手术后内分泌病改善率的总体合并率为48%(95%CI:29%-69%)。术后并发症发生率为8%(95%CI:4%-13%),新发生的术后DI发生率为28%(95%CI:18%-40%)。囊肿复发的合并发生率为16%(95%CI:11%-23%),再次手术发生率为14%(95%CI:8%-24%)。儿科患者RCC手术对头痛和视力障碍的症状改善率较高,不过内分泌病的改善往往中等。该手术术后并发症风险一般较低,但新发DI的发生率值得注意。虽然许多患者头痛完全缓解,但手术不应仅因头痛治疗而进行。手术决策必须优先考虑客观临床因素,如囊肿特征、神经影响和内分泌功能障碍。此外,观察到复发和再次手术率,这突出表明需要仔细考虑潜在风险并制定个体化治疗方案。未来的研究应专注于改进手术技术并评估长期结果,以优化儿科RCC患者的治疗策略。